Cargando…

The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia

Detalles Bibliográficos
Autores principales: Tran, Huyen, Deng, Lucy, Wood, Nicholas, Chen, Vivien M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665282/
http://dx.doi.org/10.1182/blood-2022-168844
_version_ 1784831257514868736
author Tran, Huyen
Deng, Lucy
Wood, Nicholas
Chen, Vivien M
author_facet Tran, Huyen
Deng, Lucy
Wood, Nicholas
Chen, Vivien M
author_sort Tran, Huyen
collection PubMed
description
format Online
Article
Text
id pubmed-9665282
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652822022-11-16 The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia Tran, Huyen Deng, Lucy Wood, Nicholas Chen, Vivien M Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665282/ http://dx.doi.org/10.1182/blood-2022-168844 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Tran, Huyen
Deng, Lucy
Wood, Nicholas
Chen, Vivien M
The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
title The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
title_full The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
title_fullStr The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
title_full_unstemmed The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
title_short The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
title_sort clinicalpathological features of vaccine-induced immune thrombocytopenia and thrombosis (vitt) following chadox1 (astrazeneca azd1222) vaccination and case outcomes in australia
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665282/
http://dx.doi.org/10.1182/blood-2022-168844
work_keys_str_mv AT tranhuyen theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia
AT denglucy theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia
AT woodnicholas theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia
AT chenvivienm theclinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia
AT tranhuyen clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia
AT denglucy clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia
AT woodnicholas clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia
AT chenvivienm clinicalpathologicalfeaturesofvaccineinducedimmunethrombocytopeniaandthrombosisvittfollowingchadox1astrazenecaazd1222vaccinationandcaseoutcomesinaustralia